VC Investment Surges In Q2 As Financial Market Recovery Momentum Builds
Anecdotal Evidence Of Improvement Backed By Data
Even after removing Xaira’s unusual $1bn seed financing, Evaluate’s data show that biopharma venture capital fundraising increased from the first to the second quarter and from Q2 of last year.
